In a recent lecture, top specialist Dr. Krüger, MD, said that “We’re seeing turbo cancers after the mRNA vaccine.”
Dr. Krüger, MD, is a pathologist who specializes in diseases of the breast. Her lecture concerned changes in breast cancer cases following introduction of Spike generating genetic drug therapy.
“I’m very pleased to have the opportunity to speak as a member of the Physician’s Appeal, Läkaruppropet. Thank you all to my colleagues who organized this important conference and to all of you for coming.
You may be wondering about the title of my lecture. But more on that later.
At the beginning of the COVID-19 outbreak, I researched on the Internet and found that the mortality rate following infection with the coronavirus was around 2%. In comparison, sarcoidosis is an inflammatory disease, and the most important interstitial lung disease in Western Europe is described as having a mortality rate of just under 5%.
Subscribe to GreatGameIndia
Enter your email address to subscribe to GGI and receive notifications of new posts by email.
Have you ever heard anything in the media about sarcoidosis, which has a much higher mortality rate than COVID-19?
In addition, in medical school, I was given a different definition of the term “pandemic than we used today. In the period that followed, I observed the events very closely.”
I’ve been working in pathology for 25 years. For the last 19 years, I was mainly involved in the diagnosis of breast specimens. Almost eight years ago, I got the opportunity to work in breast cancer research at Lund University. Here I have reevaluated 1,500 breast cancer cases according to currently valid guidelines.
With this experience, I know approximately the distribution of average age, tumor size, and degree of malignancy that I can expect in the daily input material of breast cancer.
According to a recent study, more cases of heart inflammation than expected have been seen in people who received the COVID-19 vaccination from Novavax.
You can read more about this topic here.
This content was originally published here.
